ID   CP4F8_HUMAN             Reviewed;         520 AA.
AC   P98187;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Cytochrome P450 4F8;
DE            EC=1.14.14.1;
DE   AltName: Full=CYPIVF8;
GN   Name=CYP4F8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Seminal vesicle;
RX   PubMed=10405341; DOI=10.1006/bbrc.1999.1011;
RA   Bylund J., Finnstroem N., Oliw E.H.;
RT   "Gene expression of a novel cytochrome P450 of the CYP4F subfamily in
RT   human seminal vesicles.";
RL   Biochem. Biophys. Res. Commun. 261:169-174(1999).
RN   [2]
RP   FUNCTION.
RX   PubMed=10791960; DOI=10.1074/jbc.M001712200;
RA   Bylund J., Hidestrand M., Ingelman-Sundberg M., Oliw E.H.;
RT   "Identification of CYP4F8 in human seminal vesicles as a prominent 19-
RT   hydroxylase of prostaglandin endoperoxides.";
RL   J. Biol. Chem. 275:21844-21849(2000).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=12464258; DOI=10.1016/S0003-9861(02)00511-8;
RA   Stark K., Toermae H., Cristea M., Oliw E.H.;
RT   "Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human
RT   epithelia and prominent induction in epidermis of psoriatic lesions.";
RL   Arch. Biochem. Biophys. 409:188-196(2003).
RN   [4]
RP   FUNCTION, VARIANT PHE-125, AND MUTAGENESIS OF GLY-328.
RX   PubMed=16112640; DOI=10.1016/j.abb.2005.07.003;
RA   Stark K., Wongsud B., Burman R., Oliw E.H.;
RT   "Oxygenation of polyunsaturated long chain fatty acids by recombinant
RT   CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of
RT   CYP4F8.";
RL   Arch. Biochem. Biophys. 441:174-181(2005).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15789615; DOI=10.1016/j.prostaglandins.2004.09.014;
RA   Stark K., Bylund J., Toermae H., Sahlen G., Oliw E.H.;
RT   "On the mechanism of biosynthesis of 19-hydroxyprostaglandins of human
RT   seminal fluid and expression of cyclooxygenase-2, PGH 19-hydroxylase
RT   (CYP4F8) and microsomal PGE synthase-1 in seminal vesicles and vas
RT   deferens.";
RL   Prostaglandins Other Lipid Mediat. 75:47-64(2005).
CC   -!- FUNCTION: Hydroxylates arachidonic acid (20:4n-6) to (18R)-
CC       hydroxyarachidonate. Shows little activity against prostaglandin
CC       (PG) D2, PGE1, PGE2, PGF2alpha, and leukotriene B4. Catalyzes
CC       omega-2 and omega-3-hydroxylation of PGH1 and PGH2. Catalyzes
CC       epoxidation of 4,7,10,13,16,19-(Z)-docosahexaenoic acid (22:6n-3)
CC       and 7,10,13,16,19-(Z)-docosapentaenoic acid (22:5n-3) and omega-3-
CC       hydroxylation of 4,7,10,13,16-(Z)-docosapentaenoic acid (22:5n-6).
CC       Catalyzes hydroxylation of PGI2 and carbaprostacyclin.
CC       {ECO:0000269|PubMed:10791960, ECO:0000269|PubMed:15789615,
CC       ECO:0000269|PubMed:16112640}.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=7 uM for 9-alpha,11-alpha-epoxymethano-PGH2 (U-44069);
CC         KM=40 uM for 6,9-alpha-methylene-PGI2;
CC         Note=The Vmax of the reaction with U-44069 as substrate is 260
CC         pmol/min/pmol enzyme.;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.
CC       Microsome membrane {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in the epithelium of seminal
CC       vesicles, in renal cortex, in adult and fetal liver, in epidermis,
CC       in corneal epithelium, in sweat glands, hair follicles, epithelial
CC       linings of the ampulla of vas deferens and of the stomach and
CC       small intestine, as well as in the transitional epithelium of the
CC       bladder and ureter (at protein level). In the epidermis, expressed
CC       from the basal cell to the granular cell layers. In the corneal
CC       epithelium, expressed in all cell layers. Also detected in
CC       prostate. Up-regulated in the epidermis of psoriatic lesions.
CC       {ECO:0000269|PubMed:10405341, ECO:0000269|PubMed:12464258,
CC       ECO:0000269|PubMed:15789615}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF133298; AAD49566.1; -; mRNA.
DR   CCDS; CCDS74303.1; -.
DR   RefSeq; NP_009184.1; NM_007253.3.
DR   UniGene; Hs.268554; -.
DR   ProteinModelPortal; P98187; -.
DR   SMR; P98187; -.
DR   BioGrid; 116439; 2.
DR   SwissLipids; SLP:000001467; -.
DR   iPTMnet; P98187; -.
DR   PhosphoSitePlus; P98187; -.
DR   BioMuta; CYP4F8; -.
DR   DMDM; 10719963; -.
DR   EPD; P98187; -.
DR   MaxQB; P98187; -.
DR   PeptideAtlas; P98187; -.
DR   PRIDE; P98187; -.
DR   DNASU; 11283; -.
DR   Ensembl; ENST00000612078; ENSP00000477567; ENSG00000186526.
DR   GeneID; 11283; -.
DR   KEGG; hsa:11283; -.
DR   UCSC; uc032hoh.2; human.
DR   CTD; 11283; -.
DR   DisGeNET; 11283; -.
DR   GeneCards; CYP4F8; -.
DR   HGNC; HGNC:2648; CYP4F8.
DR   HPA; HPA058960; -.
DR   MIM; 611545; gene.
DR   neXtProt; NX_P98187; -.
DR   OpenTargets; ENSG00000186526; -.
DR   PharmGKB; PA405; -.
DR   GeneTree; ENSGT00760000118816; -.
DR   HOGENOM; HOG000233833; -.
DR   HOVERGEN; HBG000182; -.
DR   InParanoid; P98187; -.
DR   KO; K17728; -.
DR   OMA; GCTQDVV; -.
DR   OrthoDB; EOG091G06KN; -.
DR   PhylomeDB; P98187; -.
DR   Reactome; R-HSA-211935; Fatty acids.
DR   Reactome; R-HSA-211979; Eicosanoids.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   SABIO-RK; P98187; -.
DR   ChiTaRS; CYP4F8; human.
DR   GeneWiki; CYP4F8; -.
DR   GenomeRNAi; 11283; -.
DR   PRO; PR:P98187; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   CleanEx; HS_CYP4F8; -.
DR   ExpressionAtlas; P98187; baseline and differential.
DR   Genevisible; P98187; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0018685; F:alkane 1-monooxygenase activity; TAS:ProtInc.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0006690; P:icosanoid metabolic process; TAS:Reactome.
DR   GO; GO:0006693; P:prostaglandin metabolic process; TAS:ProtInc.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Heme; Iron; Membrane;
KW   Metal-binding; Microsome; Monooxygenase; Oxidoreductase; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    520       Cytochrome P450 4F8.
FT                                /FTId=PRO_0000051855.
FT   TRANSMEM     15     37       Helical. {ECO:0000255}.
FT   METAL       468    468       Iron (heme axial ligand). {ECO:0000250}.
FT   VARIANT     125    125       Y -> F (no effect on U-44069 and 9,11-
FT                                diazo-prostadienoic acid (U-51605)
FT                                hydroxylation; loss of 20:4n-6 or 22:5n-6
FT                                oxidation; dbSNP:rs2072600).
FT                                {ECO:0000269|PubMed:16112640}.
FT                                /FTId=VAR_038347.
FT   VARIANT     447    447       P -> Q (in dbSNP:rs2056822).
FT                                /FTId=VAR_038348.
FT   MUTAGEN     328    328       G->E: No effect on U-44069 and U-51605
FT                                hydroxylation. 20:4n-6 hydroxylation
FT                                shifted from C-18 to C-19.
FT                                {ECO:0000269|PubMed:16112640}.
SQ   SEQUENCE   520 AA;  59995 MW;  6839640CF4E9EB86 CRC64;
     MSLLSLSWLG LRPVAASPWL LLLVVGASWL LARILAWTYA FYHNGRRLRC FPQPRKQNWF
     LGHLGLVTPT EEGLRVLTQL VATYPQGFVR WLGPITPIIN LCHPDIVRSV INTSDAITDK
     DIVFYKTLKP WLGDGLLLSV GDKWRHHRRL LTPAFHFNIL KPYIKIFSKS ANIMHAKWQR
     LAMEGSTCLD VFEHISLMTL DSLQKCIFSF DSNCQEKPSE YITAIMELSA LVVKRNNQFF
     RYKDFLYFLT PCGRRFHRAC RLVHDFTDAV IQERRRTLTS QGVDDFLQAK AKSKTLDFID
     VLLLSEDKNG KELSDEDIRA EADTFMFGGH DTTASGLSWV LYNLARHPEY QERCRQEVQE
     LLKDREPKEI EWDDLAQLPF LTMCLKESLR LHPPIPTFAR GCTQDVVLPD SRVIPKGNVC
     NINIFAIHHN PSVWPDPEVY DPFRFDPENA QKRSPMAFIP FSAGPRNCIG QKFAMAEMKV
     VLALTLLRFR ILPDHREPRR TPEIVLRAED GLWLRVEPLG
//
